As of June 2026, full Mexican market authorization remains unresolved
6 1
In other words, the endocrine system is robbing Peter to pay Paul
Medical News Today, 2 January 2024
LRx Italy contains approximately 70% of all reimbursed prescriptions made in retail pharmacies, while LRx France comprises data from approximately 43% of all pharmacies in the country
"For several years now, we've had a strategy to talk to our customers about treating people as people, not as diseases, realizing that, unfortunately, they have multiple conditions or diseases going on at one time, and that multiprogram platform approach has allowed us to actually sell more programs into a single customer." Omada Health, which went public in June, also tightened the bottom line, reducing its net loss to $3 million, or an adjusted loss of 6 cents per share, compared to a loss of $9 million in the third quarter of 2024